Effect of MitoQ on Platelet Function and Reactive Oxygen Species Generation in Patients With Sickle Cell Anemia (MitoQ)
Effect of MitoQ on Platelet Function and Reactive Oxygen Species (ROS) Generation in Patients With Sickle Cell Anemia
Sponsor: University of Pittsburgh
This NA trial investigates Sickle Cell Disease and is currently actively recruiting participants. University of Pittsburgh leads this study, which shows 8 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Jul 2025 — Present [monthly]
Recruiting NA
-
Sep 2024 — Jul 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
May 2023 — Jul 2024 [monthly]
Recruiting NA
-
Feb 2022 — May 2023 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Jan 2021 — Feb 2022 [monthly]
Recruiting NA
-
May 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Oct 2019 — May 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Pittsburgh
For direct contact, visit the study record on ClinicalTrials.gov .